Dextromethorphan
Dextromethorphan is a pharmaceutical drug with 71 clinical trials. Currently 6 active trials ongoing. Historical success rate of 90.4%.
Success Metrics
Based on 47 completed trials
Phase Distribution
Phase Distribution
31
Early Stage
19
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.0%
47 of 54 finished
13.0%
7 ended early
6
trials recruiting
71
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Study of Dextromethorphan in OCD and Related Disorders
Psilocybin-facilitated Treatment for Chronic Pain
A Study of Imlunestrant (LY3484356) in Female Healthy Participants
Clinical Trials (71)
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Study of Dextromethorphan in OCD and Related Disorders
Psilocybin-facilitated Treatment for Chronic Pain
A Study of Imlunestrant (LY3484356) in Female Healthy Participants
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial
A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity
Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia
A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates
Effects of Isotretinoin on CYP2D6 Activity
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder
A Study of IBI351 in Healthy Subjects
DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan
A Drug Interaction Study of LY3871801 in Healthy Participants
Dextromethorphan Added on for Children With Chronic Irritability
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 71